Physician profile
Gregory Martin
NPI 1043257728
$440,900.76
in general payments reported to CMS, 2019-2025
18 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120K · 2020: $34K · 2021: $90K · 2022: $133K · 2023: $62K · 2024: $455 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Food and Beverage: $1,062 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $60,601.23 |
| Food and Beverage | $1,062.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $437,966.92 | 2019-2023 | Itotal Identity Cruciate Retaining Knee Replacement System, Identity Imprint Knee Replacement System, Actera Hip Stem |
| Pacira Therapeutics, INC. | $1,426.42 | 2020 | |
| Zimmer Biomet Holdings, INC. | $490.46 | 2019-2025 | Mymobility Platform, Tapestry |
| Stryker Corporation | $228.16 | 2024-2025 | Triathlon, Pangea, T2 Alpha |
| Pacira Pharmaceuticals Incorporated | $184.95 | 2020-2025 | Iovera, Zilretta, Exparel |
| Vericel Corporation | $167.60 | 2019-2025 | Maci |
| Kowa Pharmaceuticals America, INC. | $79.10 | 2023 | Seglentis |
| Depuy Synthes Sales INC. | $70.48 | 2021-2024 | Monovisc |
| Vertex Pharmaceuticals Incorporated | $59.13 | 2025 | |
| Baxter Healthcare | $44.04 | 2023 | Floseal |
| Smith+Nephew, INC. | $34.84 | 2019 | |
| Bioventus LLC | $31.44 | 2020-2025 | Durolane |
| Orthofix Medical, INC. | $23.66 | 2023 | Physio-Stim |
| Nalu Medical, INC. | $23.64 | 2021 | |
| Nevro Corp. | $23.21 | 2023 | Senza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $17.02 | 2019 | |
| Medtronic, INC. | $16.85 | 2025 | Closurefast |
| Pfizer INC. | $12.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.